Track topics on Twitter Track topics that are important to you
Mack Centre IV, 4th FloorSouth 61 Paramus Road
United States of America
Phone: 201 909-3000
Fax: 201 909-3004
AkaRx, a Dova Pharmaceuticals subsidiary, gained FDA approval for its Doptelet, or avatrombopag, as a treatment for adult pat -More-
The US Food and Drug Administration (FDA) approved AkaRx Inc's Doptelet (avatrombopag) tablets to treat low blood platelet count (thrombocytopenia) in adults with chronic liver disease who are schedul...
Dova Pharmaceuticals’ subsidiary AkaRx has secured approval from the US Food and Drug Administration (FDA) for its Doptelet (avatrombopag) tablets to treat low blood platelet count (thrombocytopenia...
Top stories on December 21st, 2009: Amgen’s Denosumab poised for EU approval Celgene's Revlimid meets Multiple Myeloma trial goal Astellas forges US$ 390M oncology pact with Ambit Bioscie...
Fosun Pharma acquired China rights to an thrombocytopenia candidate from a subsidiary of Dova Pharma, AkaRx. Avatrombopag is an oral drug candidate for thrombocytopenia (low platelet count) in patient...
The AkaRx management team is made up of highly experienced, seasoned individuals who have demonstrated abilities in pharmaceutical development, registration, manufacture and commercialization. All hav...
We have published hundreds of AkaRx Inc. news stories on BioPortfolio along with dozens of AkaRx Inc. Clinical Trials and PubMed Articles about AkaRx Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of AkaRx Inc. Companies in our database. You can also find out about relevant AkaRx Inc. Drugs and Medications on this site too.
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...